Market Cap 453.79M
Revenue (ttm) 174.43M
Net Income (ttm) -138.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -79.63%
Debt to Equity Ratio 0.00
Volume 1,767,713
Avg Vol 1,465,632
Day's Range N/A - N/A
Shares Out 384.57M
Stochastic %K 76%
Beta 1.25
Analysts Sell
Price Target $1.55

Company Profile

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software, and services based upon technologies used in the identification of proteins, as well...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 266 6000
Fax: 650 871 7152
Address:
2 Tower Place, Suite 2000, South San Francisco, United States
BostonWhalerGuyI
BostonWhalerGuyI Nov. 14 at 12:48 PM
$LAB fits the coming b2b cap ex spend sweetspot in upoming consumer spending and AI market meltdown 100% new equipment immediate depreciation for firms now New focus...cash pile....amazing moated technology in expanding applications and markets...new hq out of cali......revs growing yoy.....cost containment focus....ebita profit coming......tiny float There's a reason eli is loading Mgt loaded up between 1.17-1.28 She's on the growth launch pad
0 · Reply
BostonWhalerGuyI
BostonWhalerGuyI Nov. 13 at 4:16 PM
$LAB 🔥 so many applications
0 · Reply
AZOZ
AZOZ Nov. 13 at 1:12 PM
$LAB insiders keep loading Stay tuned folks!
0 · Reply
BostonWhalerGuyI
BostonWhalerGuyI Nov. 13 at 12:25 PM
$LAB in
1 · Reply
BillyWithrow1092
BillyWithrow1092 Nov. 6 at 4:12 PM
$LAB shows consistent buying support. AITX reinforces innovation with real-time AI analytics driving measurable savings for clients.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:35 PM
TD Cowen has adjusted their stance on Standard BioTools ( $LAB ), setting the rating to Hold with a target price of 1.55 → 1.35.
0 · Reply
JamieMorin397
JamieMorin397 Nov. 5 at 4:45 PM
$LAB posts moderate movement in biotech space. AITX continues to expand international dealer presence, opening new distribution channels for its technologies.
0 · Reply
Chrisg1212
Chrisg1212 Nov. 5 at 4:18 PM
$LAB I’m in 🚀🚀🚀🚀🚀🚀
0 · Reply
Jkpga
Jkpga Nov. 5 at 3:21 PM
$LAB is this ever going to be profitable? Now next year ? Last year they said 2025 blah blah
0 · Reply
grnback
grnback Oct. 30 at 7:49 PM
$LAB Filled the gap today, finally.
0 · Reply
Latest News on LAB
Standard BioTools Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 4:01 PM EDT - 3 months ago

Standard BioTools Reports Second Quarter 2025 Financial Results


Standard BioTools Reports First Quarter 2025 Financial Results

May 6, 2025, 4:01 PM EDT - 6 months ago

Standard BioTools Reports First Quarter 2025 Financial Results


Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 9:44 PM EST - 9 months ago

Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript


Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:10 PM EDT - 1 year ago

Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript


Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 8:34 PM EDT - 1 year ago

Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript


Standard BioTools Announces Senior Leadership Changes

Jul 31, 2024, 4:02 PM EDT - 1 year ago

Standard BioTools Announces Senior Leadership Changes


Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript

May 11, 2024, 12:45 PM EDT - 1 year ago

Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript


Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:44 PM EST - 1 year ago

Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript


Standard BioTools Stockholders Approve Merger with SomaLogic

Jan 4, 2024, 10:23 PM EST - 2 years ago

Standard BioTools Stockholders Approve Merger with SomaLogic


BostonWhalerGuyI
BostonWhalerGuyI Nov. 14 at 12:48 PM
$LAB fits the coming b2b cap ex spend sweetspot in upoming consumer spending and AI market meltdown 100% new equipment immediate depreciation for firms now New focus...cash pile....amazing moated technology in expanding applications and markets...new hq out of cali......revs growing yoy.....cost containment focus....ebita profit coming......tiny float There's a reason eli is loading Mgt loaded up between 1.17-1.28 She's on the growth launch pad
0 · Reply
BostonWhalerGuyI
BostonWhalerGuyI Nov. 13 at 4:16 PM
$LAB 🔥 so many applications
0 · Reply
AZOZ
AZOZ Nov. 13 at 1:12 PM
$LAB insiders keep loading Stay tuned folks!
0 · Reply
BostonWhalerGuyI
BostonWhalerGuyI Nov. 13 at 12:25 PM
$LAB in
1 · Reply
BillyWithrow1092
BillyWithrow1092 Nov. 6 at 4:12 PM
$LAB shows consistent buying support. AITX reinforces innovation with real-time AI analytics driving measurable savings for clients.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:35 PM
TD Cowen has adjusted their stance on Standard BioTools ( $LAB ), setting the rating to Hold with a target price of 1.55 → 1.35.
0 · Reply
JamieMorin397
JamieMorin397 Nov. 5 at 4:45 PM
$LAB posts moderate movement in biotech space. AITX continues to expand international dealer presence, opening new distribution channels for its technologies.
0 · Reply
Chrisg1212
Chrisg1212 Nov. 5 at 4:18 PM
$LAB I’m in 🚀🚀🚀🚀🚀🚀
0 · Reply
Jkpga
Jkpga Nov. 5 at 3:21 PM
$LAB is this ever going to be profitable? Now next year ? Last year they said 2025 blah blah
0 · Reply
grnback
grnback Oct. 30 at 7:49 PM
$LAB Filled the gap today, finally.
0 · Reply
WHO905
WHO905 Oct. 22 at 12:16 AM
$LAB This stock just doesn’t want to move. No matter what the company does or how high the Nasdaq climbs we can’t get any movement. Even NAUT, a shot in the dark, zero revenue company just climbed from .85 to 1.40+ on no news. Why are we so dead in the water?
1 · Reply
Millones
Millones Oct. 15 at 4:31 PM
$LAB Looking good
0 · Reply
beckphan08
beckphan08 Oct. 15 at 4:17 PM
$LAB big news on way !?!?!?
1 · Reply
RiskSlinger
RiskSlinger Oct. 5 at 9:40 AM
$LAB Biotech ETF proxy. Sector volatility high. Testing key support. Volume pattern shows distribution.
0 · Reply
jjrrjjrr
jjrrjjrr Oct. 1 at 7:03 PM
0 · Reply
WHO905
WHO905 Sep. 30 at 1:35 PM
$LAB $PACB Here we go again ...
2 · Reply
amda
amda Sep. 24 at 2:54 PM
$MSFT - see news below. Is $LAB a microfluidics play? An AI search identifies their previous name, Fluidigm, as a player in this space. I see that this is not a startup - they actual have well over $100MM in revs, and no debt with the recent sale of one of their units. Microsoft dipped 1% after the technology company acknowledged in a blog post that its existing chip cooling methods will put a ceiling on its business’ AI-fueled growth over the next few years. The company also shared that it recently tested a new method of cooling silicon chips using microfluidics. $NVDA $AMD $INTC
0 · Reply
amda
amda Sep. 24 at 2:36 PM
$LAB is this a microfluidics play? An AI search identifies their previous name, Fluidigm, as a player in this space. I see that this is not a startup - they actual have well over $100MM in revs, and no debt with the recent sale of one of their units.
0 · Reply
amda
amda Sep. 24 at 1:32 PM
$LAB this looks interesting. super low float. strong balance sheet. virtually no debt.
0 · Reply
OriginalTradeonrumor
OriginalTradeonrumor Sep. 19 at 4:52 AM
$LAB bought earlier in year …so far so good as its doubled that below return 😁….$ACRS next to fly …
0 · Reply
OrganizedChaos
OrganizedChaos Sep. 17 at 10:32 PM
$LAB these guys dropoing employees like files... Not good
2 · Reply
beckphan08
beckphan08 Sep. 15 at 8:01 PM
$LAB please go to five
0 · Reply